Juan Huang, affiliated with Capital Medical University in Beijing, China, has a Scopus ID of 57226877329. She has published 12 documents, which have been cited 124 times by 124 documents, and holds an h-index of 6.
Dr. Juan Huang: Attending physician – Beijing Anding Hospital, Capital Medical University, Beijing, China
Dr. Juan Huang is an Attending Physician at Beijing Anding Hospital, Capital Medical University, with a strong background in psychiatry and mental health. She has been actively engaged in both clinical practice and academic research, with particular interest in mood disorders such as depression and bipolar disorder. Her work bridges patient care with innovative scientific inquiry, aiming to improve diagnostic accuracy, treatment precision, and long-term patient outcomes.
Online Profiles
Education
Dr. Huang completed her Bachelor of Medicine (B.Med.) in Psychiatry at Bengbu Medical College in 2013, where she built a strong foundation in psychiatric medicine. She then pursued her postgraduate training at Capital Medical University, earning a Master of Medicine (M.Med.) in Psychiatry and Mental Health in 2017. Her educational trajectory reflects a continuous commitment to academic excellence and professional specialization, equipping her with the expertise to integrate theory, research, and clinical application in psychiatry.
Research Focus
Her research primarily centers on mood disorders, with an emphasis on the clinical and biological underpinnings of depression and bipolar disorder. She is particularly interested in antidepressant resistance, biological rhythm disturbances, and personalized medicine approaches that incorporate genetic and pharmacological markers. By investigating these areas, Dr. Huang aims to contribute to precision psychiatry, enhancing the effectiveness of treatment strategies and improving patients’ quality of life.
Experience
Since joining Beijing Anding Hospital in 2017, Dr. Huang has advanced from Physician to Attending Physician, gaining comprehensive experience in clinical psychiatry. In her current role, she combines direct patient care with active involvement in multi-level research projects, clinical trials, and academic publications. Her experience reflects not only her clinical competence but also her dedication to evidence-based innovation in psychiatry, making her an active contributor to both the hospital’s clinical excellence and its academic mission.
Research Timeline & Activities
In recent years, Dr. Huang has taken part in several significant research projects at hospital, municipal, and bureau levels. Notably, she has been a participant in a large-scale randomized controlled trial investigating esketamine for antidepressant resistance, as well as studies on pharmacogenetics and therapeutic drug monitoring for depression. Additionally, she has served as the principal investigator of a hospital-level study examining biological rhythm disorders in bipolar disorder, reflecting her ability to lead independent research initiatives. These projects highlight her consistent engagement with cutting-edge psychiatric research and her active role in advancing the field.
Awards & Honors
Dr. Huang has received recognition through multiple competitive research grants, which underscore both her scientific merit and the relevance of her work to clinical psychiatry. These include funding from the Beijing Hospital Administration Center and Beijing Anding Hospital, awarded at bureau, municipal, and institutional levels.
Top Recent Publication
Among her recent academic contributions, Dr. Huang’s first-author article in Frontiers in Psychiatry (2023), titled Agomelatine in the treatment of anhedonia, somatic symptoms, and sexual dysfunction in major depressive disorder, stands out as a key work. This study highlights her focus on the nuanced symptoms of depression and the importance of personalized treatment. It reflects her broader research agenda of integrating clinical practice with innovative therapeutic strategies, making it a valuable addition to current psychiatric literature.
Here’s a summary of the new BMC Psychiatry article, titled “Serum folate and homocysteine as biomarkers for suicide risk in major depressive disorder: insights in males and younger patients”, published on 31 July 2025
- Title:
Serum folate and homocysteine as biomarkers for suicide risk in major depressive disorder: insights in males and younger patients - Authors:
Liu C, Ma Y, Zhou Y, Wang S, Li J, Zhang H, et al. - Journal:
BMC Psychiatry - Year:
2025 - Volume / Article Number:
25:745 - DOI:
10.1186/s12888-025-07183-7
Juan Huang, Medicine, Young Researcher Award